Active substance
DAPAGLIFLOZINE
Therapeutical formulation
TABLETTEN EN CAPSULES

€ 1.11 excluding delivery costs.

This drug is fully reimbursed by your health insurance company.

Own risk

€ 1.11

This is the amount charged to your deductible .

Strength
5MG
Supplier
ASTRAZENECA BV
Available outside pharmacies
No
Remarks
  • This medicine is available by prescription only.
EU number
EU/1/12/795/004

Alternatives